This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
PSMA PET Imaging
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
Trials in Progress
Trials in Progress
ECLIPSE Trial
Oral EPI-7386
SPLASH Trial
Right Side
PCCTC
DORA
IRONMAN
PROMISE
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Kidney Cancer Today
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Education
Covid-19
The Prostate Cancer Foundation
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Pelvic Health & Reconstruction
Endourology
Testicular Cancer
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
ASCO 2023
AUA 2023
ASCO GU 2023
EAU 2023
All Conferences
View All
PCF
UroToday Home
Conference Highlights
EAU 2020
EAU 2020
Prostate Cancer
Bladder Cancer
Kidney Cancer
Testicular and Penile Cancer
Press Releases
EAU 2020 Prostate Cancer
Viewing 1-20 of 48 articles
EAU 2020: Treatment of Recurrent Lymph Node Metastatic Prostate Cancer - Radiation Is the Best Option
EAU 2020: Recognising Images, Tissues, Signals
EAU 2020: The Real Effect of Prostate Cancer Treatment: EUPROMS First-Ever Prostate Patient-Driven Quality of Life Study
EAU 2020: Salvage Lymph Node Dissection in Prostate Cancer: Primary Treatment of Pelvic Lymph Node Metastatic Prostate Cancer - Systemic Only
EAU 2020: What Are the Consequences for Implants in Urology with the New EU Directive?
EAU 2020: Five Things I Wish I Would Have Known Earlier in My Career: Lessons from the Mentors - Prostate Cancer
EAU 2020: New Technology for Urology: 7T MRI Scanner
EAU 2020: Imagine All the People… Is There a Second, Digital, Me?
EAU 2020: Salvage Lymph Node Dissection in Prostate Cancer: Does Early Diagnosis Help the Patient?
EAU 2020 Treatment of Recurrent Lymph Node Metastatic Prostate Cancer - Surgery Is the Best Option
EAU 2020: Primary Treatment of Pelvic Lymph Node Metastatic Prostate Cancer - Surgery Only
EAU 2020: Primary Treatment of Pelvic Lymph Node Metastatic Prostate Cancer - Radiation Only
EAU 2020: A Prospective, Open, Multicentre, Phase II Clinical Trial of Bicalutamide Alone or With Addition of Docetaxel in Nonmetastatic Prostate Cancer With a Rising PSA (SPCG-14)
EAU 2020: Midterm Oncological Results of Focal Therapy: HIFU Focal Ablation
EAU 2020: Treatment of Polymetastatic Hormone Sensitive Prostate Cancer
EAU 2020: Late Toxicity and Quality of Life from GETUG-AFU 22 Study: A Randomised Phase II Trial Comparing 6 Months of Degarelix in Combination with Radiotherapy to Radiotherapy Alone for Patients with Detectable PSA After Radical Prostatectomy
EAU 2020: Case-based Debate PSMA-targeted Radioligand Therapy: Which Patients, Which Stages? Treatment Options: Medical oncologist, Nuclear medicine, and Urologist Perspectives
EAU 2020: Imaging of Castrate-resistant Prostate Cancer - What is Possible, What is Necessary
EAU 2020: What Should You Do with Men You Do Not Biopsy, or Whose Biopsy Is Negative?
EAU 2020: Limitations of PSMA Based on Prostate Cancer Biology
1
2
3
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free